LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $42,346,000 | -7.1% | 309,254 | -7.7% | 0.63% | -6.1% |
| Q3 2017 | $45,599,000 | +29.1% | 334,919 | +15.1% | 0.67% | +33.7% |
| Q2 2017 | $35,332,000 | +253.5% | 291,037 | +208.2% | 0.50% | +260.0% |
| Q1 2017 | $9,995,000 | +11.0% | 94,431 | +6.6% | 0.14% | +11.1% |
| Q4 2016 | $9,002,000 | -28.6% | 88,597 | -28.3% | 0.13% | -23.6% |
| Q3 2016 | $12,614,000 | -47.7% | 123,594 | -38.9% | 0.16% | -41.1% |
| Q2 2016 | $24,133,000 | +42.6% | 202,341 | +28.0% | 0.28% | +53.8% |
| Q1 2016 | $16,924,000 | – | 158,034 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |